Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fiber-Optic Technology Helps Heal Wounds Faster

By HospiMedica International staff writers
Posted on 21 Feb 2016
A new technique helps deliver light deeper into human tissue, potentially healing wounds faster and treating tumors more efficiently.

Developed by researchers at the University of St. More...
Andrews (Fife, United Kingdom) and Harvard Medical School (Boston, MA, USA), Pohang University of Science and Technology (Gyeongsangbuk-do, Republic of Korea), and other institutions, the technology is based on photochemical tissue bonding (PTB) based on biocompatible, biodegradable polymers. The polymers are used to fabricate optical waveguides which can be inserted into the body to deliver light to heal internal wounds locally, for example after surgery.

The implantable light-delivery waveguides may be used for long-term light delivery, and need not be removed as they are gradually resorbed by the tissue. Using a comb-shaped planar waveguide, the researchers were able to achieve full thickness (over 10 mm) wound closure of porcine skin, which represents around a 10-fold extension of tissue depth achievable with conventional PTB. According to the researchers, the results point to potential photomedicine uses in deep tissues. The study was published on January 19, 2016, in Nature Communications.

“The potential applications of biodegradable polymer waveguides are expected to go far beyond PTB,” concluded lead author Sedat Nizamoglu, PhD, of Harvard Medical School and Koç University (Istanbul, Turkey), and colleagues. “Implantable waveguides can extend the therapeutic depths in photodynamic and photothermal therapies; enable deep tissue stimulation by low-level light or optogenetic techniques; and offer new strategies for continuous monitoring of medical conditions and sensing diagnostic information.”

“A variety of optical techniques, such as photochemical tissue bonding and photodynamic therapy, require efficient delivery of light deep into tissues, but the current limited penetration of light in tissue constitutes a serious constraint in clinical use,” added study coauthor Prof. Malte Gather, PhD, of the University of St. Andrews. “Having biocompatible and bioabsorbable optical components may transform photomedicine from a discipline where light is predominantly applied externally, to a new paradigm based on tissue-integrated and precisely controlled delivery and collection of light.”

Related Links:

University of St Andrews
Harvard Medical School
Pohang University of Science and Technology



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.